NCCRED Round 2 Seed Funding Grants closing soon
No Images? Click here
Seed Funding Grant Round Closing Soon!
NCCRED is releasing Grants to fund innovative Clinical Research for the treatment of substance use disorder due to methamphetamine or emerging drugs of concern.
$500,000 is available in Round 2 of funding! Applications close on 15th April.
Funding
This funding will provide financial support as a seed-funding grant to establish investigator-initiated research.
Grant applications will be reviewed by the independent NCCRED Methamphetamine and Emerging Drugs Working Group and presented to the NCCRED Board for support of funding. For more information on the Grants funding process, to access the guidelines and application form or to contact us with any questions, please follow the link below.
Key Dates
Applications open: 18 Jan 19
Applications close: 15 Apr 19
Applications reviewed: 04 Jun 19
NCCRED Board awards funding: 05 Jul 19
Applicants are notified of results: 15 Jul 19
Final study report due to NCCRED: 31 Dec 20
Applicants considering submission should contact the NCCRED Clinical Research Lead, Krista Siefried, to discuss the grants further.
Applicants that were previously unsuccessful are encouraged to re-apply.
Applicants can also email with any further questions about the grants or NCCRED.
Mentorship
Register here if you would like to be linked with a Mentor to provide assistance in conceptualising your project or developing your funding application.
To stay informed about NCCRED, get involved, or get updates about future funding rounds, please sign up to our newsletter via the link below.
The National Centre for Clinical Research on Emerging Drugs is made up of a consortium of the following four institutions
|
|
The National Centre for Clinical Research on Emerging Drugs of Concern is Funded By
 |  |
Please unsubscribe if you no longer wish to receive these emails.
